The options have an exercise price of
About
Contact:
CBO & CFO
T: 857-999-0890
E: ben.palleiko@kalvista.com
(C) 2022 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.97 USD | -1.84% |
|
+19.09% | +22.20% |
12/07 | Needham Adjusts Price Target on KalVista Pharmaceuticals to $32 From $35, Maintains Buy Rating | MT |
11/07 | KalVista Pharmaceuticals Files $300 Million Mixed Shelf | MT |
The options have an exercise price of
About
Contact:
CBO & CFO
T: 857-999-0890
E: ben.palleiko@kalvista.com
(C) 2022 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+22.20% | 65Cr | |
+7.46% | 10TCr | |
+11.97% | 4.23TCr | |
-11.76% | 3.28TCr | |
+79.34% | 2.95TCr | |
-12.20% | 1.63TCr | |
+4.00% | 1.44TCr | |
-1.90% | 1.22TCr | |
+178.17% | 1.05TCr | |
+1.80% | 896.68Cr |